Ian Berry (@LaughingGenome) header
Ian Berry (@LaughingGenome) profile picture

clinical laboratory geneticist, exome sequencer, science enthusiast, husband, father

Leeds, England
Joined July 2017
Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)Photo by Ian Berry (@LaughingGenome)
Just finished analysing our 500th developmental disease (paeds & perinatal) clinical exome in Leeds Genetics Lab. Proud our 50% Dx yield (combination of clinician-ordered panels, exome-wide CNV & phenotype-agnostic variant hunting) holding steady! Well done all! #Genomics #NHS
2
8
1
29
So you’re telling me, after nearly quarter of a century of GWAS, after which they’ve discovered not very much about human heritability, that GWAS outcomes are mostly noise? That is… somewhat predictable, I guess (p < 5 × 10−8).
On reflection, I think this paper actually burys the lede about association studies. A more pointed conclusion might be that many tens or hundreds of millions of dollars in functional follow-up on disease-variant associations [1] have been essentially wasted, and are continuing to be wasted, chasing biological noise. Oops. The lines of reasoning is about as follows. If we assume: 1. Most traits are highly polygenic, such that in the limit approximately every gene is associated (via a regulatory association) to every trait 2. Ranking single-variant associations by 'significance' is effectively arbitrary because the ranking is dominated by allele frequencies/drift Then: 3. Any gene prioritization that comes from a single-variant association study (as currently analyzed) is uninformative about trait biology [2]. 4. Functional studies looking to understand the impact of the 'top' GWAS hits for traits are not in fact studying the most 'important' genes for those traits, but rather an effectively random subset of genes 5. The amount of money spent on the functional studies in point 4 measures at least in the tens or hundreds of millions of dollars over the past decade, and probably billions [3] Am I missing something @spence_jeffrey_ @Hakha_Most @jkpritch ? --- [1] E.g. grants.nih.gov/grants/guide/… and many others like it [2] But note the single-variant ranking is of course extremely important for trait prediction and applications where 'realized heritability' is what matters [3] NHGRI budget alone is ~$700M/year genome.gov/sites/default/fil…
3
252
Nearly a clean sweep of the top five for ⁦@NickLutsko⁩ … open.spotify.com/wrapped/sha…
1
6
3,139
And this isn’t at all dangerous or ethically questionable…
Try submitting x-ray, PET, MRI or other medical images to Grok for analysis. This is still early stage, but it is already quite accurate and will become extremely good. Let us know where Grok gets it right or needs work.
114
And, presumably, identifying all those who have a nonorganic form of kidney disease. Massively under-diagnosed worldwide. In England, the Genomic Medicine Service has ensured more equitable access, including whole genome sequencing for suspected genetic cystic renal disease.
Study of kidney disease hospitalizations finds that genetic kidney disease leads to higher & more costly admissions than non-genetic chronic kidney disease, highlighting the need for tailored secondary prevention & resource allocation bit.ly/3U0kpHa @AndrewMallett8 #GIMO
3
2
9
889
Nonorganic = monogenic! Autocorrect woes, although strangely somewhat accurate, could’ve been worse 😂
3
74
Classifying genomic variants? Have case control data for PS4? Try our new tool, the PS4-Likelihood Ratio Calculator (turnbull-lab.shinyapps.io/ps…). jmg.bmj.com/content/early/20… Allows user to define the odds ratio (representing anticipated underlying strength of disease association for a gene). A likelihood ratio towards pathogenicity (or benignity) is then generated based on the observed case and control variant frequencies. In our new paper in @JMG_BMJ, we demonstrate applications of PS4-LR-Calc tool, such as a breast cancer susceptibility gene, a rare paediatric disease gene and a variant of suspected reduced penetrance. More flexible quantitative evaluation of case-control data: should be useful in forthcoming ‘points-based’ ACMG/AMP framework update. @CRUKresearch funding for @CanGeneCanVar. Collaboration with @CRowlandsBio, @nickywhiffin (@bdi_oxford), @AlchemiJones (@ICR_London) and CanVIG-UK scientists/clinicians @BurghelG, @MirandaDurkie. @McVeighTerri @acgs_news @BritSocGenMed
6
16
1,377
Really great story! I didn’t knit the aftermath of “Eric the Eel”’s Olympic journey until today.
You probably know the start of this Olympic story, but do you know how it finished? This photo is of Eric Moussambani, aka 'Eric the Eel' from Equatorial Guinea, competing in the 100m Freestyle event at the Sydney 2000 Olympics, alone. Why? /1
184
Really welcome change, this is a fantastic dataset now on the UK’s (maybe the world’s?) premium clinical genomics browser, enhancing the interpretation of CNVs in array and WGS testing.
The structural variant genome track has been updated to @gnomad_project v4.1 – 1,199,117 high quality structural variants identified in 63,046 genomes from unrelated individuals
1
1
1
9
644
Well yeah this is great but, erm, it has big gaps where water can get through?
Dry-stacked interlocked masonry. It enables affordable building construction, speedier construction (up to 50% in time saving) and relatively high quality with enhanced aesthetic properties.
201
I wrote about the latest attempt to sell genetic IQ prediction and why it is snake oil. A short 🧵:
28
266
45
1,184
442,885
Just voted. Turnout low and polling station staffed entirely by bewildered primary school children. Make of that what you will.
39
811
19
5,200
408,373
One of my least favorite journalistic tropes in the world is asking politicians if they know how much a loaf of bread, pint of milk etc costs. Stupid meaningless gotcha-ism. I’m not sure I could tell you either.
Ben Thompson: You appear to be in a supermarket.. do you know how much a loaf of bread costs Rishi Sunak: £1.35 RT: Do you know how much that loaf of bread has gone up by in the last 5 years RS: No... Waffle.. waffle RT: It's gone up by 28% according to the ONS #BBCBreakfast
1
208
Ian Berry retweeted
Why I'm so irritated by the Conservatives' attack on Starmer for work-life balance: it's just one of a host of examples of real improvements in UK living standards that don't cost, opposed by the less-enlightened. See this chart, others that follow: 1/ – at Wandsworth, London
21
109
15
667
114,269
🧬New rare disease solved ! Happy to share our latest work on the developmental disorder associated to a recurrent missense variant in FEM1B (1/5) sciencedirect.com/science/ar…
2
8
1
26
3,239
I had several Amigas through the early 90s and don’t remember the 87 version at all. I think they all had the 85 typography.
Amiga clearly peaked in 1985.
2
158
A wonderful day in Taunton spreading the Genomics love to SW healthcare scientists and hearing lots of inspirational talks. @SWGenomics @SWGLH
Colleagues from @SWGenomics presenting on the SW Genomic Medicine Service & the genomics laboratory hub & workforce. Genomics are critical to driving personalised medicine with a national genomic test directory supporting the application of genomics into practice. #SWHCSCONF24
1
1
6
294
Psycho killer. Qu'est-ce que c'est?
240
2,025
321
13,216
919,521
Ian Berry retweeted
An important update from Rob Taylor, Sian Ellard, and Emma Baple providing the ACGS position statement on rare disease diagnostic genomic testing in the UK and Ireland. #ACGS2024 @taylorlabncl @EllardSian @RDExeter
7
2
23
3,026
Forced to work in the rain unnecessarily? Join a union.
761
12,260
1,410
54,167
2,577,484